Zavamed.com: Pharmaceuticals and More - Page 2

Generic drugs are just as safe and effective as brand-name medications but cost up to 85% less. Learn how they’re made, tested, and approved by the FDA through the ANDA process-step by step.

Menopause weight gain isn't about overeating-it's hormonal shifts, muscle loss, and a slower metabolism. Learn the science-backed strategies to fight belly fat and protect your long-term health.

Generics are the backbone of affordable healthcare worldwide, saving billions annually and making life-saving drugs accessible in low-income countries. Yet patent barriers and rising drug prices threaten their impact.

Many common OTC drugs like Sudafed, Benadryl, and Ambien are banned or restricted abroad. Learn which medications can get you arrested overseas and how to travel safely with your prescriptions.

Ordering medication from foreign websites may save money, but it puts your life at risk. Counterfeit drugs are widespread, often deadly, and nearly impossible to detect. Learn how to avoid them and stay safe.

Expired medications aren't always dangerous, but they're rarely reliable. Learn which pills are safe to use after expiration, which ones can harm you, and how to store and dispose of them properly.

Learn how to talk to your doctor about generic vs. brand-name medications-when generics work just as well, when to ask for the brand, and how to save money without risking your health.

NTI generics require stricter regulation than standard generics due to narrow margins between effective and toxic doses. This article explores how the FDA, EMA, Canada, and Japan differ in their approaches, what’s changing in 2025, and why prescribers must stay cautious.

Supportive care in cancer uses growth factors, antiemetics, and pain relief to manage treatment side effects, improve survival, and keep patients on track. Learn how these evidence-based tools work and why access remains unequal.

In 2025, the U.S. government expanded its drug shortage response with a new API stockpile program, but gaps in enforcement, funding, and economic incentives leave hospitals and patients vulnerable to ongoing shortages of critical medications.